Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 27;25(1):428.
doi: 10.1186/s12882-024-03882-7.

Prevalence and risk factors of osteoporosis in lupus nephritis patients in China: a cross-sectional study

Yu Hong  1 , Yi Yang #  2 , Ying Yao #  1   3
Affiliations

Prevalence and risk factors of osteoporosis in lupus nephritis patients in China: a cross-sectional study

Yu Hong et al. BMC Nephrol. .

Abstract

Background: Osteoporosis is a significant concern among individuals with lupus nephritis (LN), with reported prevalence rates exhibiting considerable variation. This study investigates the prevalence and identifies risk factors contributing to osteoporosis in premenopausal and postmenopausal LN patients, addressing the paucity of data specific to the Chinese population.

Methods: This cross-sectional study enrolled patients with renal biopsy-proven LN, who underwent bone mineral density (BMD) measurements using dual X-ray absorptiometry at the lumbar spine, total hip, and femoral neck. The study was conducted at Tongji hospital from May 2011 to June 2018.

Results: A total of 130 patients were evaluated, with a mean age of 46.2 ± 12.9 years, including 2 males and 128 females. A significant majority, 52.3% (n = 67) of the female patients, were identified as postmenopausal. BMD measurements revealed that 40.0% of patients had osteoporosis in at least one site. The spearman rank correlation of BMD with clinical characteristics indicated that age at menopause, weight, height, and body mass index were positively correlated with BMD, while age, age at diagnosis of LN, and menopause duration were negatively correlated with BMD in lumbar spine, total hip, and/or femoral neck. Multivariable linear regression analysis demonstrated that body mass index was positively associated with BMD, whereas disease duration and menopause duration were negatively associated with BMD in all and postmenopausal patients. Postmenopausal patients consistently had a higher prevalence of osteoporosis across all measured sites. Factors such as older age, lower weight, and the absence of bisphosphonates therapy were independently associated with an increased risk of osteoporosis in LN patients.

Conclusion: Our findings underscore a substantial prevalence of osteoporosis in LN patients, especially among postmenopausal individuals. The study identifies older age, lower weight, and absence of bisphosphonates treatment as risk factors for osteoporosis in this patient population.

Keywords: Bone mineral density; Lupus nephritis; Osteoporosis; Risk factor.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study protocol was approved by the Ethical Committee of Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology (Project No. TJ-IRB20181106). This study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and informed consent was obtained from each patient. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–91. - PubMed
    1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82(5):299–308. - PubMed
    1. Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7. - PubMed
    1. Stojanowski J, Konieczny A, Rydzynska K, Kasenberg I, Mikolajczak A, Golebiowski T, Krajewska M, Kusztal M. Artificial neural network - an effective tool for predicting the lupus nephritis outcome. BMC Nephrol. 2022;23(1):381. - PMC - PubMed
    1. Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-kappaB and MAPK signalling pathways in MRL/lpr mice. BMC Nephrol. 2022;23(1):243. - PMC - PubMed

LinkOut - more resources